Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postoperative Glucose Control with a Basal Bolus Versus Sliding Scale Insulin Regimen and Its Effect on the Incidence of Surgical Site Infections in People with Type 2 Diabetes Mellitus.

NCT06638567 is registered in ClinicalTrials.gov with Abraham Hulst, MD, PhD as lead sponsor.

NCT NCT06638567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06638567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postoperative Glucose Control with a Basal Bolus Versus Sliding Scale Insulin Regimen and Its Effect on the Incidence of Surgical Site Infections in People with Type 2 Diabetes Mellitus.
Lead sponsor
Abraham Hulst, MD, PhD
Phase
Not applicable
Overall status
Recruiting
Start date
January 3, 2025
Completion date
September 30, 2027
Enrollment
1,008 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, surgical site infection